WHO CLASSIFICATION OF NEOPLASMS FROM MATURE T-LYMPHOCYTES, NK-CELLS, HISTIOCYTES AND DENDRITIC CELLS (revision 2016)
Keywords:
WHO classification, T-cells, NK-cells, neoplasms.Abstract
Summary. In WHO classification (2016) some advances
have occured in definition of nodal and extranodal T-cell
and natural killer-cell neoplasms. Many of changes are the
result of genomic studies using new approaches. Histiocytic and dendritic cells tumors are grouped together based
on the functional properties of their normal counterpart.
References
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision
of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127 (20): 2375–90.
Swerdlow SH, Campo E, Harris NL, et al.(eds). WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon:
IARC Press, 2008. 439 p.
Lemonnier F, Couronné L, Parrens M, et al. Recurrent TET2
mutations in peripheral T-cell lymphomas correlate with TFHlike features and adverse clinical parameters. Blood 2012; 120 (7):
–9.
Nicolae A, Pittaluga S, Venkataraman G, et al. Peripheral T-cell lymphomas of follicular T-helper cell derivation with
Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol 2013; 37
(6): 816–26.
Moroch J, Copie-Bergman C, de Leval L, et al.Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics. Am J Surg Pathol 2012; 36 (11): 1636–46.
Iqbal J, Wright G, Wang C, et al. Lymphoma leukemia molecular profiling project and the international peripheral T-cell lymphoma project. Gene expression signatures delineate biological and
prognostic subgroups in peripheral T-cell lymphoma. Blood 2014;
(19): 2915–23.
Palomero T, Couronné L, Khiabanian H, et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet 2014; 46 (2): 166–70.
Agnelli L, Mereu E, Pellegrino E, et al.European T-Cell Lymphoma Study Group. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic
large-cell lymphoma. Blood 2012; 120 (6): 1274–81.
Attygalle AD, Cabeçadas J, Gaulard P, et al. Peripheral Tcell and NK-cell lymphomas and their mimics; taking a step forward — report on the Lymphoma Workshop of the XVIth meeting
of the European Association for Haematopathology and the Society for Hematopathology. Histopathology 2014; 64 (2): 171–99.
Parrilla Castellar ER, Jaffe ES, Said JW, et al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous
disease with widely disparate clinical outcomes. Blood 2014; 124
(9): 1473–80.
Karai LJ, Kadin ME, Hsi ED, et al.Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis.
Am J Surg Pathol 2013; 37 (8): 1173–81.
Saggini A, Gulia A, Argenyi Z, et al.A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases. Am
J Surg Pathol 2010; 34 (8): 1168–75.
Miranda RN, Aladily TN, Prince HM, et al. Breast implantassociated anaplastic large-cell lymphoma: long-term follow-up
of 60 patients. J Clin Oncol 2014; 32 (2): 114–20.
Petrella T, Maubec E, Cornillet-Lefebvre P, et al. Indolent
CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma? Am J Surg Pathol 2007; 31 (12):
–92.
Guitart J, Weisenburger DD, Subtil A, et al. Cutaneous
γδ T-cell lymphomas: a spectrum of presentations with overlap
with other cytotoxic lymphomas. Am J Surg Pathol 2012; 36 (11):
–65.
Jerez A, Clemente MJ, Makishima H, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders
of NK cells and T-cell large granular lymphocyte leukemia. Blood
; 120 (15): 3048–57.
Rajala HL, Eldfors S, Kuusanmäki H, et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.
Blood 2013; 121 (22): 4541–50.
Nicolae A, Xi L, Pittaluga S, et al. Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas. Leukemia 2014; 28
(11): 2244–8.
Küçük C, Jiang B, Hu X, et al. Activating mutations of
STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
Nat Commun 2015; 6: 6025.
Deleeuw RJ, Zettl A, Klinker E, et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma
reveals 2 distinct lymphoma subtypes. Gastroenterology 2007; 132
(5): 1902–11.
Tomita S, Kikuti YY, Carreras J, et al. Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan. Mod Pathol 2015; 28 (10): 1286–96.
Chan JK, Chan AC, Cheuk W, et al.Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent
γδ T-cell receptor expression. Am J Surg Pathol 2011; 35 (10): 1557–69.
Garcia-Herrera A, Colomo L, Camós M, et al. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous
group of tumors with different clinicopathologic features and outcome. J Clin Oncol 2008; 26 (20): 3364–71.
Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NKcell lymphoproliferative diseases in nonimmunocompromised hosts:
prospective analysis of 108 cases. Blood 2012; 119 (3): 673–86.
Quintanilla-Martinez L, Ridaura C, Nagl F, et al. Hydroa
vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative
disorder with risk to develop a systemic lymphoma. Blood 2013; 122
(18): 3101–10.
Haroche J, Abla O. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease. Hematolology Am Soc Hematol Educ Program 2015;
(1): 571–8.
Shao H, Xi L, Raffeld M, et al. Clonaly related histiocytic/
dendritic cell sarcoma and chronic lymphocytic leukemia/small
lymphocytic lymphoma: a study of seven cases. Mod Pathol 2011;
(11): 1421–32.
Dalia S, Shao H, Sagatys E, et al. Dendritic cell and histiocytic neoplasms: biology, diagnosis, and treatment. Cancer Control
; 21 (4): 290–300.
Go H, Jeon YK, Huh J, et al. Frequent detection of
BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.
Histopathology 2014; 65 (2): 261–72.
